HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Prostaglandin D2

HCID 448457
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
41598-07-6
Standard SMILES
CCCCC[C@H](O)/C=C/[C@H]1C(=O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O
InChIKey
BHMBVRSPMRCCGG-OUTUXVNYSA-N
Molecular formula
C20H32O5
Average molar mass
352.5 g/mol
Monoisotopic mass
352.22497412

Overview

Prostaglandin D2 is a member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- stereoisomer). It has a role as a mouse metabolite and a human metabolite. It is a conjugate acid of a prostaglandin D2(1-).

Names & identifiers

Preferred name
Prostaglandin D2
IUPAC
(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid
English name
PROSTAGLANDIN D2
Molecular formula
C20H32O5
Molecular weight
352.47

Names & synonyms

prostaglandin D2PGD241598-07-611-Dehydroprostaglandin F2-alphaBRN 217062311-Dehydroprostaglandin F2alphaRXY07S6CZ211-Dehydroprostaglandin F2 alphaDTXSID30897162(Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-3-oxocyclopentyl]hept-5-enoic acid(5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate(5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate
Show more names
PGDSProstaglandin D?PROSTAGLANDINS D22PROSTAGLANDIN D2PGD2 (Prostaglandin D2)RP23-47P18.11-006, 21kDa11-dehydroprostaglandinf2-alpha
9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoic acidCHEBI:15555(5Z,13E,15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acidProsta-5,13-dien-1-oic acid, 9,15-dihydroxy-11-oxo-, (5Z,9-alpha,13E,15S)-D2, Prostaglandin11 Dehydroprostaglandin F2alpha11 Dehydroprostaglandin F2 alphaF2alpha, 11-Dehydroprostaglandin

Properties

Computed structural properties

XLogP
2.6
Topological polar surface area
94.8 Ų
Hydrogen bond donors
3
Hydrogen bond acceptors
5
Rotatable bonds
12
Heavy atoms
25
Formal charge
0
Complexity
469

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15
LipidsFatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]
Melting Point56 - 57 °C
Physical DescriptionSolid
Collision Cross Section · 4 items

186.5 Ų [M-2H2O-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

196.63 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

192.4 Ų [M+Na]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]

189.4 Ų [M-H]-

Physicochemical properties

Melting point
68 °C · 68°C
Boiling point
406.07 °C · 406.07°C (rough estimate)
alpha
7.5 ° · +7.5°(D/21℃)(c=1,THF)
Density
1.0601 · 1.0601 (rough estimate)

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

F
10
PPE
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
3
rtecs
UK7930000
risk_code
60-22
Signal word
Danger
Symbol(GHS)
GHS07,GHS08
hazard_code
T
safety_code
53-22-26-36
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard statements
H302-H360
Hazard Classifications
Acute Tox. 4 OralRepr. 1B
Precautionary statements
P201-P301+P312+P330-P308+P313

Chemistry & industry

Pharmacology

Tissue LocationsAdipose Tissue
Cellular LocationsCytoplasm
Metabolite PathwaysAcetaminophen Action Pathway
Applications · 2 items

DescriptionProstaglandin D2 (PGD2) is the major eicosanoid product of mast cells and is released in large quantities during allergic and asthmatic anaphylaxis. Mastocytosis patients produce excessive amounts of PGD2, which causes vasodilation, flushing, hypotension, and syncopal episodes. PGD2 is also produced in the brain via an alternative pathway involving a soluble, secreted PGD-synthase also known as β-trace. In the brain, PGD2 produces normal physiological sleep and lowering of body temperature. Further pharmacological actions include inhibition of platelet aggregation and relaxation of vascular smooth muscle. PGD2 inhibits human ovarian tumor cell proliferation with an IC50 of 6.8 μM.

UsesProstaglandin D2 is a fatty acid compound present in the human body. Elevated levels of localized Prostaglandin D2 has been linked to hair loss and growth inhibition. It has also been seen to contribute to the activity of allergic asthma.

Upstream & downstream products

Upstream raw materials

Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-oxo-, (5Z,9α,13E,15S)- (9CI)Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-hydroxy-, (5Z,9α,11α,13E,15S)- (9CI)

Related reactions

24 records
New reaction record
HRID 6685 reaction equation
HRID 6685As product
HRID 258641 reaction equation
HRID 258641As reactant
HRID 258642 reaction equation
HRID 258642As product
HRID 328229 reaction equation
HRID 328229As reactant
HRID 328230 reaction equation
HRID 328230As product
HRID 436951 reaction equation
HRID 436951As product
HRID 457460 reaction equation
HRID 457460As product
HRID 477215 reaction equation
HRID 477215As product
PreviousPage 1 of 3

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
41598-07-6
PubChem CID
448457
DTXSID
DTXSID30897162
ChEMBL
CHEMBL1235252
ChEBI
CHEBI:15555
UNII
RXY07S6CZ2
EC Number
636-995-9
Nikkaji
J16.416J
refractive index
1.612 · 1.6120 (estimate)
storage temp.
-20 °C · -20°C
solubility
Chloroform (Slightly), Ethanol (Slightly), Methanol (Slightly), THF (Slightly)
form
White solid
pka
4.76 · 4.76±0.10(Predicted)
color
White to Light Orange
biological source
synthetic
BRN
2170623 · 2170623
Stability
Light Sensitive
InChIKey
BHMBVRSPMRCCGG-OUTUXVNYSA-N
SMILES
[H][C@]1(C\C=C/CCCC(O)=O)[C@@H](O)CC(=O)[C@]1([H])\C=C\[C@@H](O)CCCCC
FDA UNII
7 S6CZ2 · RXY07S6CZ2
UNSPSC Code
12352211 · 12352211
NACRES
77 · NA.77
Symbol(GHS)
7 · GHS07,GHS08
Signal word
Danger
Hazard statements
302 · H302-H360
Precautionary statements
201 · P201-P301+P312+P330-P308+P313
PPE
3 · Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
T
Risk Statements
60 · 60-22
Safety Statements
53 · 53-22-26-36
WGK Germany
3 · 3
RTECS
7930000 · UK7930000
F
10 · 10
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
4 OralRepr · Acute Tox. 4 OralRepr. 1B
Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-hydroxy-, methyl ester, (5Z,9α,11α,13E,15S)- (9CI)
Prosta-5,13-dien-1-oic acid, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-11-[(tetrahydro-2H-pyran-2-yl)oxy]-, methyl ester, (5Z,9α,11α,13E,15S)- (9CI)
Prosta-5,13-dien-1-oic acid, 15-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-9-hydroxy-11-[(tetrahydro-2H-pyran-2-yl)oxy]-, methyl ester, (5Z,9α,11α,13E,15S)- (9CI)
5-Heptynoic acid, 7-oxo-, methyl ester
2H-Pyran, tetrahydro-2-[[(1S)-1-[(1E)-2-iodoethenyl]hexyl]oxy]-
(4R)-(+)-t-Butyldimethylsiloxy-2-cyclopenten-1-one

Additional notes

DefinitionChEBI: A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- s ereoisomer).